Enbrel cost $350 mil.
Executive Summary
Immunex estimates it cost $350 mil. to bring Enbrel (etanercept) to market. The investment could make future endeavors more efficient, CEO Ed Fritzky says Sept. 24. "Once you have researchers who understand rheumatology, you can leverage that with your next rheumatology molecule. But nevertheless, I don't think anyone should have the expectation where it's going to cost a lot less to move molecules through the pipeline"